Related Experiment Video
Updated: Mar 26, 2026

Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2
Published on: May 23, 2025
Exosome-associated AAV vector as a robust and convenient neuroscience tool
E Hudry1,2, C Martin1,2, S Gandhi1,2
1Alzheimer Research Unit, The Massachusetts General Hospital Institute for Neurodegenerative Disease, Charlestown, MA, USA.
Exosomes carrying adeno-associated virus (AAV) vectors, termed exo-AAV, offer a simplified purification method for neuroscience research. Exo-AAV efficiently transduces central nervous system cells after systemic delivery and evades neutralizing antibodies.
Area of Science:
- Neuroscience
- Gene Therapy
- Molecular Biology
Background:
- Adeno-associated virus (AAV) vectors are crucial for gene therapy and neuroscience research.
- Current AAV purification methods are costly, labor-intensive, and time-consuming.
- AAV can associate with exosomes (exo-AAV) during isolation from producer cell media, showing increased resistance to neutralizing antibodies.
Purpose of the Study:
- To demonstrate that simple ultracentrifugation of exo-AAV yields high-titer vector preparations.
- To evaluate the efficiency of exo-AAV for transducing central nervous system (CNS) cells after systemic delivery in mice.
- To assess the potential of exo-AAV as a simplified and effective neuroscience research tool.
Main Methods:
- Isolation of AAV associated with exosomes (exo-AAV) from conditioned media.
- Purification of exo-AAV via simple ultracentrifugation and pelleting.
- Systemic injection of exo-AAV in mice to assess CNS transduction efficiency.
- Comparison of exo-AAV with conventionally purified AAV at low vector doses.
- Assessment of cellular toxicity and visualization of transduced cells using GFP fluorescence and two-photon tomography.
Main Results:
- Simple pelleting of exo-AAV resulted in high-titer vector preparations.
- Exo-AAV demonstrated more efficient gene delivery to the brain than conventional AAV at low doses, even for serotypes not typically crossing the blood-brain barrier.
- Similar cell types were transduced by both exo-AAV and conventional AAV.
- No cellular toxicity was observed in cells transduced with exo-AAV.
- Successful three-dimensional reconstruction of transduced Purkinje cells in the cerebellum was achieved.
Conclusions:
- Exo-AAV purification is simpler and more efficient than conventional methods.
- Exo-AAV facilitates effective gene delivery to the CNS after systemic administration, even for difficult-to-transduce serotypes.
- Exo-AAV evades neutralizing antibodies, making it clinically relevant for peripheral delivery to the CNS.
- The ease of isolation and high transduction efficiency position exo-AAV as a valuable tool for neuroscience research.
More Related Videos
10:15Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Published on: September 15, 2014
08:11Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
Published on: August 25, 2017